Edouard Yeramian
Overview
Explore the profile of Edouard Yeramian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
595
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Reynaert M, Dupoiron D, Yeramian E, Marsollier L, Brodin P
Toxins (Basel)
. 2019 Sep;
11(9).
PMID: 31487908
Pain currently represents the most common symptom for which medical attention is sought by patients. The available treatments have limited effectiveness and significant side-effects. In addition, most often, the duration...
2.
Degnonvi H, Fleuret S, Coudereau C, Gnimavo R, Giffon S, Yeramian E, et al.
Lancet Planet Health
. 2019 Aug;
3(8):e349-e356.
PMID: 31439316
Background: Buruli ulcer is the third most common mycobacterial disease worldwide. The public health burden of this neglected tropical disease is large, particularly in poor areas of west and central...
3.
Song O, Queval C, Iantomasi R, Delorme V, Marion S, Veyron-Churlet R, et al.
EMBO Rep
. 2017 Nov;
19(1):29-42.
PMID: 29141986
The interaction of (Mtb) with pulmonary epithelial cells is critical for early stages of bacillus colonization and during the progression of tuberculosis. Entry of Mtb into epithelial cells has been...
4.
Queval C, Song O, Carralot J, Saliou J, Bongiovanni A, Deloison G, et al.
Cell Rep
. 2017 Sep;
20(13):3188-3198.
PMID: 28954234
Pathogens have evolved a range of mechanisms to counteract host defenses, notably to survive harsh acidic conditions in phagosomes. In the case of Mycobacterium tuberculosis, it has been shown that...
5.
Song O, Kim H, Jouny S, Ricard I, Vandeputte A, Deboosere N, et al.
Toxins (Basel)
. 2017 Jul;
9(7).
PMID: 28718822
Mycolactone, a polyketide molecule produced by , is the etiological agent of Buruli ulcer. This lipid toxin is endowed with pleiotropic effects, presents cytotoxic effects at high doses, and notably...
6.
Song O, Marion E, Comoglio Y, Babonneau J, Guerineau N, Sandoz G, et al.
Med Sci (Paris)
. 2016 Mar;
32(2):156-8.
PMID: 26936171
No abstract available.
7.
Marion E, Chauty A, Yeramian E, Babonneau J, Kempf M, Marsollier L
Int J Mycobacteriol
. 2016 Jan;
3(2):158-61.
PMID: 26786340
Buruli ulcer is a cutaneous mycobacterial disease caused by Mycobacterium ulcerans, whose incidence is increasing steadily, especially in West Africa. This study reports a first documented case of M. ulcerans...
8.
Dia N, Lavie L, Faye N, Metenier G, Yeramian E, Duroure C, et al.
BMC Genomics
. 2016 Jan;
17:34.
PMID: 26744270
Background: The microsporidian Encephalitozoon cuniculi is an obligate intracellular eukaryotic pathogen with a small nuclear genome (2.9 Mbp) consisting of 11 chromosomes. Although each chromosome end is known to contain...
9.
Marion E, Song O, Christophe T, Babonneau J, Fenistein D, Eyer J, et al.
Cell
. 2014 Jun;
157(7):1565-76.
PMID: 24949969
Mycobacterium ulcerans, the etiological agent of Buruli ulcer, causes extensive skin lesions, which despite their severity are not accompanied by pain. It was previously thought that this remarkable analgesia is...
10.
Melanitou E, Tekaia F, Yeramian E
Gene
. 2012 Oct;
512(1):161-5.
PMID: 23031813
Type 1 diabetes (T1D) represents a serious health burden in the world, complicated by the fact that disease onset can be preceded by a long time period without evident clinical...